The Evolving Role of ctDNA to Detect Minimal Residual Disease: Implications for the Management of Colorectal Cancer (Enduring)

Discuss the evolving role of circulating tumor DNA in the management of colorectal cancer.

Learning Objectives

Enhance knowledge of the role of ctDNA to Detect Minimal Residual Disease

Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 0.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Registration Opens: 
10/08/2021
Registration Expires: 
10/07/2023
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 0.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Please login or register to take this course.